Search results

1881 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA
Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
Located in News / 2020 / March
Patient Centered Outcomes Research Institute awards funding to address research priorities in health care for women with diabetes
Wanda Nicholson, MD, MPH, MBA, director of the Diabetes and Obesity Core at the UNC Center for Women’s Health Research and member of the UNC Diabetes Center, will partner with Wendy Bennett, MD, MPH, of Johns Hopkins University, to create an online network to engage women with diabetes.
Located in Vital Signs / 2016 / June 2
Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.
Located in News / 2020 / March
UNC Lineberger discovery would allow researchers to fine-tune activity of cancer-hunting immune cells
Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, reported new findings about the regulation of co-stimulatory molecules that could be used to activate cancer-killing immune cells – chimeric antigen receptor T-cells, or CAR-T. The molecules could also be used to decrease the activity of these cells.
Located in News / 2020 / January
UNC-led study comparing tradeoffs of benefit, harm, and cost in hematuria evaluation published in JAMA Internal Medicine
UNC researchers led by Matthew Nielsen, MD, found that the risk stratification may optimize the balance of benefit, harm, and cost associated with diagnostic testing for a common condition called hematuria.
Located in Vital Signs / 2019 / Oct. 10
UNC Lineberger Research Provides New Insights Into Deadly Brain Cancer
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
Located in Vital Signs / Archives / Vital Signs - Jan. 21, 2010
VIDEO: Training birth attendants in developing countries increases babies’ survival
The study was conducted in six countries. Researchers from UNC-Chapel Hill School of Medicine took part in the study in the Democratic Republic of Congo, in partnership with the Kinshasa School of Public Health.
Located in Vital Signs / 2010 / Vital Signs - Feb. 25, 2010
Moll honored by National Alliance for Thrombosis and Thrombophilia
Stephan Moll, M.D., associate professor of hematology/oncology, received the first Medical and Scientific Leadership Award given by the National Alliance for Thrombosis and Thrombophilia (NATT).
Located in Vital Signs / 2008 / December
FOAs for Revision Applications for Evidence Based Research Related to Human Subjects Protection
Please see below for the links to the five FOAs for revision supplements for evidence based research related to human subjects protection.
Located in Vital Signs / 2012 / April 26
UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic
UNC's Dr. Adaora A. Adimora and her fellow researchers examine factors responsible for the stark racial disparities in HIV infection in the U.S. and the now concentrated epidemic among African Americans.
Located in Vital Signs / Archives / Vital Signs - Oct. 9, 2009